Taipei, Taiwan

Olga K Kosheleva

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
2 patents (USPTO):

Title: Olga K Kosheleva: Innovator in Cancer Therapy

Introduction

Olga K Kosheleva is a prominent inventor based in Taipei, Taiwan. She has made significant contributions to the field of cancer therapy through her innovative research and patented technologies. With a total of 2 patents, her work focuses on utilizing nanoparticles in conjunction with ultrasound to combat breast cancer and other forms of cancer.

Latest Patents

Kosheleva's latest patents include groundbreaking methods for reducing the growth of breast cancer cells. One patent details the use of nanoparticles, which can be gold or magnetic, to expose cancer cells to focused, low to medium power ultrasound. This method can also involve attaching a cancer drug, such as an antibody-based cancer drug, to the nanoparticles. Another patent outlines similar methods for killing cancer cells and treating cancer in subjects, utilizing various types of nanoparticles, including gold, iron oxide, copper, silver, polystyrene, PEG, or liposome nanoparticles.

Career Highlights

Olga K Kosheleva is affiliated with Academia Sinica, where she conducts her research and develops her innovative therapies. Her work has garnered attention for its potential to improve cancer treatment outcomes and enhance the effectiveness of existing therapies.

Collaborations

Kosheleva collaborates with esteemed colleagues, including Peter Lai and Nelson G Chen, to further her research and expand the impact of her inventions in the medical field.

Conclusion

Olga K Kosheleva is a trailblazer in the realm of cancer therapy, with her innovative use of nanoparticles and ultrasound showing great promise in the fight against cancer. Her contributions to the field are invaluable and continue to inspire future research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…